Published in Int J Cancer on October 21, 1997
A human breast cell model of preinvasive to invasive transition. Cancer Res (2008) 1.79
The molecular pathology of breast cancer progression. J Pathol (2010) 1.65
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34
Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer (2007) 1.27
The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res (2003) 1.20
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. Virchows Arch (2005) 1.20
A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data. Stat Med (2010) 1.18
Preinvasive breast cancer. Annu Rev Pathol (2010) 1.08
Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies. Diagn Pathol (2010) 1.06
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene (2006) 1.01
Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin Cancer Res (2008) 1.00
Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes. Gene (2011) 0.96
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge. Clin Cancer Res (2010) 0.93
Variation in RNA expression and genomic DNA content acquired during cell culture. Br J Cancer (2004) 0.92
Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions. Breast Cancer Res (2012) 0.87
Evaluation of breast cancer polyclonality by combined chromosome banding and comparative genomic hybridization analysis. Neoplasia (2001) 0.87
Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer. Breast Cancer Res (2007) 0.86
Human BCAS3 expression in embryonic stem cells and vascular precursors suggests a role in human embryogenesis and tumor angiogenesis. PLoS One (2007) 0.85
NUCKS overexpression in breast cancer. Cancer Cell Int (2009) 0.84
Increased levels of active c-Src distinguish invasive from in situ lobular lesions. Breast Cancer Res (2009) 0.84
Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival. Cancer Prev Res (Phila) (2011) 0.81
DNA copy number aberrations in breast cancer by array comparative genomic hybridization. Genomics Proteomics Bioinformatics (2009) 0.80
Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Mol Oncol (2014) 0.79
Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast. World J Surg Oncol (2010) 0.78
[Lobular neoplasms and invasive lobular breast cancer]. Pathologe (2014) 0.76
Comparative genomic hybridization analysis of invasive ductal breast carcinomas in the Chinese population. Oncol Lett (2015) 0.75
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet (1995) 6.60
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer (1994) 5.52
Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer (1998) 4.22
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res (1997) 4.02
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol (2005) 4.00
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res (2000) 3.83
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol (1994) 3.48
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res (1997) 3.37
Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci U S A (1992) 3.25
Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer (1996) 3.07
Expression and nucleotide sequence of a plasmid-determined divalent cation efflux system from Alcaligenes eutrophus. Proc Natl Acad Sci U S A (1989) 2.89
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev (1991) 2.87
Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol (1994) 2.86
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J Clin Oncol (1996) 2.83
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer (2002) 2.82
Cadmium resistance from Staphylococcus aureus plasmid pI258 cadA gene results from a cadmium-efflux ATPase. Proc Natl Acad Sci U S A (1989) 2.81
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A (1998) 2.80
Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J Virol (1973) 2.75
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res (2001) 2.69
Bacterial resistance ATPases: primary pumps for exporting toxic cations and anions. Trends Biochem Sci (1989) 2.56
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol (2000) 2.41
A digital atlas of breast histopathology: an application of web based virtual microscopy. J Clin Pathol (2004) 2.40
Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer (2000) 2.24
Genome screening by comparative genomic hybridization. Trends Genet (1997) 2.23
Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci U S A (2001) 2.16
Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst (2001) 2.13
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst (1995) 2.10
Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. J Clin Oncol (1992) 2.10
Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol (1993) 2.09
Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol (2000) 2.07
The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol (1997) 2.06
Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer (1999) 2.05
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res (1997) 2.03
Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer (1989) 2.02
Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol (2000) 2.01
Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer (1987) 2.01
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med (1991) 1.99
Nucleotide sequence and expression of the mercurial-resistance operon from Staphylococcus aureus plasmid pI258. Proc Natl Acad Sci U S A (1987) 1.99
Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res (1994) 1.93
Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res (2000) 1.92
A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res (1996) 1.89
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst (2000) 1.86
Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res (1997) 1.83
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer. Genes Chromosomes Cancer (1999) 1.82
Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol (1995) 1.81
Computer image analysis of comparative genomic hybridization. Cytometry (1995) 1.80
Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol (1998) 1.77
Nucleotide sequence of a regulatory region controlling alginate synthesis in Pseudomonas aeruginosa: characterization of the algR2 gene. Gene (1989) 1.73
Endothelial-like cells derived from human CD14 positive monocytes. Differentiation (2000) 1.73
Functional analysis of gapped microbial genomes: amino acid metabolism of Thiobacillus ferrooxidans. Proc Natl Acad Sci U S A (2000) 1.70
Mercury operon regulation by the merR gene of the organomercurial resistance system of plasmid pDU1358. J Bacteriol (1989) 1.69
Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours. J Pathol (2006) 1.68
Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology (1997) 1.66
Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome. Ann Oncol (2007) 1.64
Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.63
Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res (1994) 1.63
Presentation of poisoned patients to accident and emergency departments in the north of England. Hum Exp Toxicol (1996) 1.61
Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer. Cancer Res (2001) 1.60
Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.59
p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res (1999) 1.57
Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res (1996) 1.52
Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol (1994) 1.52
Post-irradiation malignant mesothelioma. Cancer (1996) 1.52
Schwann cell seeded guidance tubes restore erectile function after ablation of cavernous nerves in rats. J Urol (2004) 1.51
A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors. Mod Pathol (1991) 1.50
Solitary fibrous tumor involving the renal capsule. Am J Surg Pathol (1996) 1.50
Feasibility of non-invasive measurement of tissue pH using near-infrared reflectance spectroscopy. J Clin Monit (1996) 1.46
Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer (1993) 1.44
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol (1999) 1.42
PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene (2008) 1.41
Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry (1994) 1.39
HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene (1997) 1.39
Corpora cavernosa ultrastructure in vascular erectile dysfunction. J Urol (1990) 1.39
Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Hum Pathol (1993) 1.39
Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res (1995) 1.38
Cloning and DNA sequence of a plasmid-determined citrate utilization system in Escherichia coli. J Bacteriol (1985) 1.36
Overcoming cellular senescence in human cancer pathogenesis. Genes Dev (1998) 1.36
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst (1992) 1.36
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Clin Cancer Res (1997) 1.36
Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol (1999) 1.35
Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer (1997) 1.35
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization. J Pathol (1998) 1.34
Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res (1995) 1.34
Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer (1998) 1.34
Cloning, nucleotide sequence, and expression of the chromate resistance determinant of Pseudomonas aeruginosa plasmid pUM505. J Bacteriol (1990) 1.34